These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7744143)

  • 1. Value of morphometry as an independent prognostic factor in renal cell carcinoma.
    Ruiz JL; Hernández M; Martínez J; Vera C; Jimenez-Cruz JF
    Eur Urol; 1995; 27(1):54-7. PubMed ID: 7744143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective nuclear morphometry as a prognostic factor of survival in renal cell carcinoma.
    Monge JM; Val-Bernal JF; Buelta L; García-Castrillo L; Asensio L
    Histol Histopathol; 1999 Jan; 14(1):119-23. PubMed ID: 9987656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of isolated invasion of the renal vein in renal adenocarcinoma].
    Gutiérrez Baños JL; Martín García B; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; Concepción Masip T; Fernández Gómez JM
    Actas Urol Esp; 1991; 15(5):455-8. PubMed ID: 1807126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear morphometry in prognosis of renal adenocarcinoma.
    Gutierrez JL; Val-Bernal JF; Garijo MF; Buelta L; Portillo JA
    Urology; 1992 Feb; 39(2):130-4. PubMed ID: 1736504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of microvascular invasion in predicting survival in renal cell carcinoma.
    Santiago-Agredano B; Álvarez-Kindelán J; Font-Ugalde P; Blanca-Pedregosa A; López-Beltrán A; Requena-Tapia MJ
    Actas Urol Esp; 2013 Sep; 37(8):504-12. PubMed ID: 23623182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma.
    Eskelinen M; Lipponen P; Aitto-Oja L; Hall O; Syrjänen K
    Int J Cancer; 1993 Oct; 55(4):547-54. PubMed ID: 8406980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of morphometric nuclear image analysis using the Feulgen reaction in renal cell carcinoma.
    Lee JS; Jung JJ; Lee MC; Park CS; Juhng SW; Oh BR; Moon JD
    Anal Quant Cytol Histol; 2000 Feb; 22(1):31-6. PubMed ID: 10696458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients.
    Targonski PV; Frank W; Stuhldreher D; Guinan PD
    J Urol; 1994 Nov; 152(5 Pt 1):1389-92. PubMed ID: 7933166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.
    Lang H; Lindner V; Letourneux H; Martin M; Saussine C; Jacqmin D
    Eur Urol; 2004 Sep; 46(3):331-5. PubMed ID: 15306103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Tumor Pseudocapsule Status and its Prognostic Significance in Renal Cell Carcinoma.
    Xi W; Wang J; Liu L; Xiong Y; Qu Y; Lin Z; Chen X; Wang Z; Xu J; Guo J
    J Urol; 2018 Apr; 199(4):915-920. PubMed ID: 29128576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy.
    Jeon HG; Choi DK; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Ann Surg Oncol; 2016 Jan; 23(1):321-7. PubMed ID: 26045392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
    de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
    Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.
    Gonçalves PD; Srougi M; Dall'lio MF; Leite KR; Ortiz V; Hering F
    J Urol; 2004 Aug; 172(2):470-4. PubMed ID: 15247705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preoperative prognostic model predicting recurrence-free survival for patients with kidney cancer.
    Yaycioglu O; Eskicorapci S; Karabulut E; Soyupak B; Gogus C; Divrik T; Turkeri L; Yazici S; Ozen H;
    Jpn J Clin Oncol; 2013 Jan; 43(1):63-8. PubMed ID: 23159766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of microvessel count in low stage renal cell carcinoma.
    Yoshino S; Kato M; Okada K
    Int J Urol; 1995 Jul; 2(3):156-60. PubMed ID: 8536130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.
    van der Poel HG; Mulders PF; Oosterhof GO; Schaafsma HE; Hendriks JC; Schalken JA; Debruyne FM
    Cancer; 1993 Nov; 72(9):2667-74. PubMed ID: 8402488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.